Dendritcellebaseret cancervaccine
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Dendritcellebaseret cancervaccine. / Burgdorf, Stefan K; Claësson, Mogens H; Rosenberg, Jacob.
I: Ugeskrift for læger, Bind 168, Nr. 14, 2006, s. 1420-3.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Dendritcellebaseret cancervaccine
AU - Burgdorf, Stefan K
AU - Claësson, Mogens H
AU - Rosenberg, Jacob
N1 - Keywords: Antigens, Neoplasm; Cancer Vaccines; Dendritic Cells; Humans; Lymphocyte Activation; T-Lymphocytes
PY - 2006
Y1 - 2006
N2 - The varieties of treatments for patients with cancer have increased rapidly during the last few years. One of the newer ways to treat cancer patients is by immune therapy using tumor antigen pulsed dendritic cell-based vaccination. Phase I and II trials have shown effectiveness in generating an immunologic response and have in some cases shown clinical responses with tumour regression. This paper describes some of the possibilities and perspectives for dendritic cell vaccines for cancer patients. Udgivelsesdato: 2006-Apr-3
AB - The varieties of treatments for patients with cancer have increased rapidly during the last few years. One of the newer ways to treat cancer patients is by immune therapy using tumor antigen pulsed dendritic cell-based vaccination. Phase I and II trials have shown effectiveness in generating an immunologic response and have in some cases shown clinical responses with tumour regression. This paper describes some of the possibilities and perspectives for dendritic cell vaccines for cancer patients. Udgivelsesdato: 2006-Apr-3
M3 - Tidsskriftartikel
C2 - 16584669
VL - 168
SP - 1420
EP - 1423
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 14
ER -
ID: 10155623